News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Characterizing Tumor-Immune interactions in Lung Cancer Development
Photos of Humam Kadara and Linghua Wang
Aug 21, 2024, 19:46

Characterizing Tumor-Immune interactions in Lung Cancer Development

NCI Systems Biology shared a post on X:

“Researchers MD Anderson Cancer Center, including Humam Kadara and Linghua Wang, are characterizing spatial and temporal tumor-immune interactions in Lung Cancer development.”

Source: NCI Systems Biology/X

cancer Humam Kadara Linghua Wang NCI Systems Biology OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 3, 2025, 00:40
THE LEAP trial at ASCO 2025 : Lenvatinib+pembrolizumab and chemotherapy vs.chemotherapy in a/mGEA
Oncolibrary
Jun 3, 2025, 00:22
Trial Updates at ASCO 2025: Neoadjuvant Pembrolizumab, Dabrafenib, and Trametinib in BRAF V600E-Mutated ATC
Blog
Jun 2, 2025, 18:21
Richard Lee: SIO Team Presented Real-World Implementation of ASCO-SIO Guidelines at ASCO25
Blog
Jun 2, 2025, 18:13
Chris Poulios: ASCO25 Sessions Include Patients' Perspective Along With Clinical and Laboratory-Focused Talks
Blog
Jun 2, 2025, 18:07
Sebastian Szmit: Right Ventricle in Patients With Cancer
Blog
Jun 2, 2025, 18:00
Shabnam Gujadhur: Day 2 at ASCO - Innovation, Insights, and Inspiration
Blog
Jun 2, 2025, 17:43
Gilberto Lopes Highlights Key Insights from Lung Oral Session at ASCO25
Blog
Jun 2, 2025, 17:33
Shivani Modi: Honored to Present Our Poster on Quantifying Financial Toxicity in Oncology at ASCO25
Blog
Jun 2, 2025, 17:18
Narjust Florez: Couldn’t Ask for a Better Partner as New IASLC Board Member
Blog
Jun 2, 2025, 17:06
Yüksel Ürün Highlights ML-integrated Biomarker Insights from CheckMate 9ER
Oncolibrary
Jun 2, 2025, 15:48
JAVELIN Bladder Medley Results: Avelumab + SG vs Avelumab in 1L Maintenance of Advanced UC
Blog
Jun 2, 2025, 15:40
Key Insights by Martin Zapata Laguado from ASCO25